Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Vaccinations01:51

Vaccinations

51.0K
Overview
51.0K
Development of Immunocompetence01:22

Development of Immunocompetence

731
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
731
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.8K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
International Nursing Organizations II01:28

International Nursing Organizations II

1.3K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.3K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

900
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
900

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Newborns with sickle cell trait have distinct peripheral blood molecular signatures across the first week of life.

Blood. Red cells & iron·2026
Same author

Yellow fever vaccination in healthy Gambian children of different ages to establish safety and immunogenicity of a booster dose: a open-label, non-randomised, single-site, phase 3 vaccine trial.

The Lancet. Infectious diseases·2026
Same author

A multi-omics study reveals pathway-level insights and predictive biomarkers in pediatric TB.

Clinical proteomics·2026
Same author

Population-specific heterogeneity in ontogeny of the broadly-conserved blood transcriptional program during the first week of life.

Nature communications·2026
Same author

Research priorities for improved pandemic and epidemic intelligence.

The Lancet. Global health·2026
Same author

Increase in imported mupirocin-resistant <i>Staphylococcus aureus</i> from the tropics and subtropics: trends in Berlin from 2018 to 2025.

New microbes and new infections·2026

関連する実験動画

Updated: Jan 4, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.5K

予防接種:重要な進展,未完成の議題

Peter Piot1, Heidi J Larson2,3,4, Katherine L O'Brien5

  • 1Office of the Director, Vaccine Centre and Vaccine Confidence Project, London School of Hygiene & Tropical Medicine, London, UK. peter.piot@lshtm.ac.uk.

Nature
|November 8, 2019
PubMed
まとめ

ワクチン接種によって 何百万もの命が救われていますが 予防接種の範囲は 大きく違っており 世界的な予防接種プログラムで 満たされていないニーズが 持続していることを強調しています 大規模なワクチンの利用を確保することは 重要な健康上の優先事項です

さらに関連する動画

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.1K

関連する実験動画

Last Updated: Jan 4, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.5K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.1K

科学分野:

  • 公衆衛生
  • 免疫学
  • 世界保健

背景:

  • ワクチン接種は現代医学の礎石であり,子供と成人の感染性疾患による死亡率を劇的に減少させています.
  • 効果が証明されているにも関わらず,ワクチン接種率の格差は世界的にも国家内にも存在しています.
  • 科学の進歩により ワクチン開発の新たな可能性が生まれていますが ワクチンの導入には 多くの障壁があります

研究 の 目的:

  • ワクチン接種が公衆衛生に果たす 重要な役割を強調する
  • 普遍的なワクチン接種率を達成するために,満たされていないニーズと課題を特定し,対処する.
  • 継続的な投資と予防接種プログラムの優先順位付けの重要性を強調する.

主な方法:

  • 全国および地方のワクチン接種率の分析
  • ワクチンの開発と実施の経路における課題の検討
  • 免疫の社会的および健康的利益の評価

主要な成果:

  • ワクチン接種率は地域や集団によって大きく異なります.
  • 予防接種プログラムにおける大きなギャップと満たされていないニーズが依然として存在しています.
  • ワクチンの発見から広範な実施までの旅は複雑で 財政的,開発的,物流的な課題が含まれています

結論:

  • 予防接種は非常に効果的な公衆衛生の介入であり,健全な投資です.
  • ワクチンの接種率の格差をなくすことは グローバルな健康の公平性にとって 極めて重要です
  • 研究,産業,公衆衛生部門からの持続的なコミットメントは,予防接種プログラムの優先順位と改善に不可欠です.